盘点：柯达留下的企业后代

Ortho临床诊断公司

    1994年，强生公司（Johnson & Johnson）收购了伊士曼柯达公司的临床诊断分公司，并最终使其与强生的Ortho诊断公司合并，形成了目前这家公司。作为强生的子公司，它主要提供医疗诊断技术，如血液筛查设备和体外临床试验技术。比如，该公司推出了首个能筛查血液中HIV-1抗原的试剂盒，这种病毒是导致美国绝大多数艾滋病病例的元凶。但推出该产品的同年，柯达就出售了该公司，同时还以29亿美元的低价出售了非处方药生产企业Sterling Winthrop有限公司，以加快剥离其医疗保健产品生产部门。柯达此举的理由是：更加专注于核心的影像业务，同时换取现金偿还债务。

Ortho Clinical Diagnostics

    In 1994, Johnson & Johnson (JNJ,Fortune 500) acquired the Clinical Diagnostics Division of Eastman Kodak, which was eventually merged with J&J's Ortho Diagnostic to form this company. The subsidiary of Johnson & Johnson produces medical diagnostic technology, such as blood screening devices and in vitro clinical testing. For example, the company introduced the first test kit to screen blood for antigens for HIV-1, the virus responsible for the vast majority of AIDS cases in the U.S. The same year Kodak sold this division, it also sold off over-the-counter drug operation Sterling Winthrop Inc. for $2.9 billion in a greater effort to shed its health care units. The reasoning for the move: to focus more on its core imaging business and pay down debt.